137 related articles for article (PubMed ID: 6795094)
1. The role of hexamethylmelamine in advanced ovarian carcinoma treatment.
Weiss RB
Gynecol Oncol; 1981 Oct; 12(2 Pt 1):141-9. PubMed ID: 6795094
[No Abstract] [Full Text] [Related]
2. Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma.
Kardinal CG; Luce JK
Cancer Treat Rep; 1977 Dec; 61(9):1691-3. PubMed ID: 413624
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents.
Bonomi PD; Mladineo J; Morrin B; Wilbanks G; Slayton RE
Cancer Treat Rep; 1979 Jan; 63(1):137-8. PubMed ID: 105805
[No Abstract] [Full Text] [Related]
4. Hexamethylmelamine, vincristine, and methotrexate chemotherapy in advanced neoplasms.
Longacre D; Donavan M; Paladine W; Cunningham T; Sponzo R
Cancer Treat Rep; 1977 Aug; 61(5):919-22. PubMed ID: 408004
[No Abstract] [Full Text] [Related]
5. cis-Platinum-hexamethylmelamine therapy of advanced ovarian cancer.
Lopez JA; Krikorian JG; Dias SF; Spiers AS; Finkel HE; Barnard DE
Gynecol Oncol; 1981 Feb; 11(1):64-7. PubMed ID: 6781990
[No Abstract] [Full Text] [Related]
6. Hexamethylmelamine (altretamine) activity as a single agent in previously untreated advanced ovarian cancer.
Wharton JT
Cancer Treat Rev; 1991 Mar; 18 Suppl A():15-21. PubMed ID: 1904304
[No Abstract] [Full Text] [Related]
7. Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.
Johnson BL; Fisher RI; Bender RA; DeVita VT; Chabner BA; Young RC
Cancer; 1978 Nov; 42(5):2157-61. PubMed ID: 102417
[TBL] [Abstract][Full Text] [Related]
8. Therapy of small cell carcinoma of the lung with hexamethylmelamine.
Huang MN; Takita H; Catane H; Yee Chen T
Oncology; 1978; 35(1):29-32. PubMed ID: 203884
[TBL] [Abstract][Full Text] [Related]
9. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
Edmonson JH; Wieand HS; McCormack GW
J Natl Cancer Inst; 1988 Sep; 80(14):1172-3. PubMed ID: 3137360
[No Abstract] [Full Text] [Related]
10. "Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?".
Bruckner HW
Cancer Treat Rep; 1987 Jun; 71(6):666-8. PubMed ID: 3107816
[No Abstract] [Full Text] [Related]
11. Phase II evaluation of hexamethylmelamine in advanced breast cancer: a Southwest Oncology Group study.
Fabian CJ; Rasmussen S; Stephens R; Haut A; Smith F; Balcerzak S; Tranum B
Cancer Treat Rep; 1979 Aug; 63(8):1359-61. PubMed ID: 113095
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer.
Hauge MD; Long HJ; Hartmann LC; Edmonson JH; Webb MJ; Su J
Invest New Drugs; 1992 Nov; 10(4):299-301. PubMed ID: 1487403
[TBL] [Abstract][Full Text] [Related]
13. Role of hexamethylmelamine in the treatment of ovarian cancer: where is the needle in the haystack?
Foster BJ; Clagett-Carr K; Marsoni S; Simon R; Leyland-Jones B
Cancer Treat Rep; 1986 Aug; 70(8):1003-14. PubMed ID: 3089597
[TBL] [Abstract][Full Text] [Related]
14. Hexamethylmelamine in mustard-resistant ovarian adenocarcinoma.
Omura GA; Greco FA; Birch R
Cancer Treat Rep; 1981; 65(5-6):530-1. PubMed ID: 6786741
[No Abstract] [Full Text] [Related]
15. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
Gershanovich ML; Livshits ME; Antipenkova VI
Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196
[TBL] [Abstract][Full Text] [Related]
16. Hexamethylmelamine. An evaluation of its role in the therapy of cancer.
Legha SS; Slavik M; Carter SK
Cancer; 1976 Jul; 38(1):27-35. PubMed ID: 820422
[TBL] [Abstract][Full Text] [Related]
17. Single-agent adriamycin followed by combination hexamethylmelamine-cyclophosphamide for advanced ovarian carcinoma.
Wharton JT; Herson J; Edwards CL; Griffith AB
Gynecol Oncol; 1982 Oct; 14(2):262-70. PubMed ID: 6813202
[No Abstract] [Full Text] [Related]
18. cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.
Lund B; Aabo K; Rørth M; Hansen HH
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1089-92. PubMed ID: 6819145
[TBL] [Abstract][Full Text] [Related]
19. Hexamethylmelamine: an evaluation of its role in the treatment of ovarian cancer.
Wharton JT; Rutledge F; Smith JP; Herson J; Hodge MP
Am J Obstet Gynecol; 1979 Apr; 133(7):833-44. PubMed ID: 219695
[TBL] [Abstract][Full Text] [Related]
20. Phase I--II study of hexamethylmelamine plus dibromodulcitol in refractory carcinoma of the breast.
Van Amburg AL; Presant CA; Vélez-García E; Klahr C
Cancer Treat Rep; 1979 Jan; 63(1):141-2. PubMed ID: 105806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
